Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Fed policymakers see rebound ahead, even if no herd immunity
    Finance

    Fed policymakers see rebound ahead, even if no herd immunity

    Published by linker 5

    Posted on February 12, 2021

    5 min read

    Last updated: January 21, 2026

    Thomas Barkin, President of the Richmond Federal Reserve Bank, addresses the economic rebound despite COVID-19 challenges, highlighting consumer spending and vaccine rollout issues. This image relates to the ongoing finance discussion in the article.
    Federal Reserve Bank President Thomas Barkin discusses economic rebound amid COVID-19 - Global Banking & Finance Review

    By Ann Saphir

    (Reuters) – A slower-than-expected vaccine rollout and the rise of coronavirus variants may make attaining herd immunity against COVID-19 difficult, but that should not stop the economy from rebounding, according to a U.S. central banker Thursday.

    “I don’t think the economy requires herd immunity,” Richmond Federal Reserve Bank President Thomas Barkin told Reuters Thursday. “Consumers who get vaccines, who have money in their pockets…are going to be free to spend,” he said.

    Analysts have long predicted economic activity will pick up as more people are vaccinated, but hopes for a quick path to a fully immunized populace have faded amid vaccine shortages and other roadblocks. President Joe Biden said earlier this week it will be “challenging” for the economy to reach herd immunity by summer’s end. Barkin’s remarks signal a growing understanding that an economic rebound and an ongoing pandemic are not mutually exclusive realities.

    Indeed, Fed policymakers have frequently expressed surprise at how quickly the job market regained steam last year after 22 million jobs evaporated in the first few months of the lockdowns, and even as the U.S. death toll rose far beyond other countries, to nearly 472,000 since the pandemic began.

    Still, there are nine million fewer jobs across America now than before the pandemic, with the worst job losses in the hard-hit leisure and hospitality industry. The pace at which consumer spending returns could directly affect how many workers get their jobs back or are able to snag other ones.

    Early signs of an expected spring revival have begun to appear in the data, with employment at small and medium-sized businesses rising slightly, and traffic to retail stores improving.

    INFLATION? NOT A WORRY

    The Biden administration is pushing for a $1.9 trillion pandemic relief package to help hard-hit workers, speed vaccine distribution, and hasten the recovery.

    Harvard University professor and former U.S. Treasury Secretary Larry Summers warn the injection of so much money into the economy could lead to overheating, sparking inflation and forcing the Fed to raise rates.

    But that’s not a concern shared by current U.S. Treasury Secretary Janet Yellen, or many at the Fed, which Yellen led from 2014 to 2018.

    “I don’t see it roaring past 2% anytime soon so I’m not so worried about that risk right now,” Philadelphia Fed President Patrick Harker told CNBC.

    The U.S. central bank has pledged to keep policy super-easy, buying at least $120 billion of bonds each month to push down on longer-term borrowing costs until there’s “substantial further progress” toward full employment and 2% inflation.

    San Francisco Federal Reserve Bank President Mary Daly told the Wall Street Journal this week she doesn’t expect the economy to meet that bar before the end of the year.

    And even once it does, the Fed plans to keep short-term rates pinned near zero until the economy reaches full employment and inflation reaches, and looks set to exceed, the 2% goal.

    “For now, we have policy in a good place,” Daly told the Journal. “The greatest risk is that we get nervous and we pull back accommodation too quickly on the fears of rapidly rising inflation or on the overconfidence that inflation’s hit our target…I would rather take the risk of letting inflation go a little bit and pulling it back than I would stopping it short and never getting there.”

    Daly, like Barkin, said she continues to expect the U.S. economy to pick up speed over the second half of the year as vaccinations against COVID-19 roll out and allow the economy to recover from the pandemic.

    Barkin on Thursday said he was surprised to hear recently from hospital administrators that only about 70% of their staff have been immunized. Meanwhile, top U.S. infectious disease doctor Anthony Fauci has said the United States may need 85% of the population vaccinated to get to true herd immunity.

    “It does make you temper somewhat your enthusiasm for the big, pent up demand, hit the ground at full speed story,” Barkin said.

    For businesses, he said, spending on big-ticket items like travel and conferences may take until the summer or longer to return because employers may “need some assurance that they are not putting their people at risk.”

    Cases and hospitalizations may drive business spending decisions more than any notion of herd immunity, Barkin said.

    But for consumers, whose spending accounts for about 70% of the U.S. economy, a vaccine may represent a license to spend on services that last year were heavily curtailed, like travel. And spending on goods, Barkin said, should also continue to be strong.

    Overall for consumer spending, Barkin said, “I’m actually quite hopeful that we see strong demand in the spring and summer.”

    (With reporting by Kanishka Singh and Bhargav Acharya in Bengaluru and Howard Schneider in Washington; Editing by Aurora Ellis and Diane Craft)

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostRoaring Kitty to testify on GameStop alongside hedge fund managers
    Next Finance PostU.S. weekly jobless claims hover at higher levels